UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) announced a $1.6 million four-year grant from the Centers for Disease Control and Prevention (CDC) to enhance awareness ...

The Global Healthy Living Foundation (GHLF) is excited to present innovative and transformative research at the American College of Rheumatology (ACR) Convergence 2024 in Washington DC. This marks ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved sarilumab for the treatment of polymyalgia rheumatica in adults who have experienced an ...

This week we are going to continue in our series of rheumatologic conditions to discuss the autoimmune condition called “PMR” or polymyalgia rheumatica. Polymyalgia rheumatica is a syndrome of pain ...

Are you struggling with persistent pain and stiffness in your shoulders, neck or hips beyond the usual aches and pains of aging? Polymyalgia rheumatica, a common inflammatory rheumatic disease ...

Autoimmune diseases happen when the body's natural defense mechanisms attack normal healthy cells. Polymyalgia rheumatica--or PMR-- is a rare autoimmune disease most often found in older women of ...

The approval was based on data from a phase 3 study which included adults with steroid-resistant active PMR who flared on at least 7.5mg per day of prednisone or equivalent during taper. The Food and ...

In a long-term follow-up study, patients with isolated polymyalgia rheumatica (PMR) and biopsy-confirmed giant cell arteritis (GCA) had no increased all-cause mortality compared with matched ...

Tofacitinib (Xeljanz) appeared highly effective against polymyalgia rheumatica (PMR) in a small single-arm trial, researchers said, suggesting another potential alternative to long-term ...